An Exploratory Clinical Study of GC012F Injection for Refractory gMG

NCT06419166 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study stopped early, before enrolling its first participant.

Conditions

Refractory Generalized Myasthenia Gravis

Interventions

DRUG: GC012F injection

Sponsor

Zhejiang University

Collaborators

[object Object]